🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines

Published 09/21/2019, 12:38 AM
UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines
UK100
-
BATS
-
AIR
-
NOVOb
-
ULVR
-
CASP
-
JYSK
-
STOXX
-
SX6P
-
SXEP
-
SX3P
-
SX7P
-
SX86P
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
(Updates to close)
By Susan Mathew and Sruthi Shankar
Sept 20 (Reuters) - European stocks clocked their fifth
straight week of gains on Friday with investors buying into the
oil and gas and banking sectors, and Novo Nordisk rising after
U.S. approval of its oral diabetes drug.
Investors also sought refuge in the so-called defensive
sectors such as utilities .SX6P , real-estate .SX86P and food
and beverages .SX3P ahead of a week packed with economic data.
The United Nations (UN) general assembly will also provide
clues on the fallout from attacks on Saudi oil facilities last
weekend and indications of a potential meeting between the
presidents of Iran and the United States. "After (the general assembly) things may become more
uncertain, so that could explain the moves into defensive
stocks," said Teeuwe Mevissen, senior market economist at
Rabobank.
"Markets are basically keeping their gunpowder dry for
afterwards when there is certainty about where things are
headed."
The pan-European STOXX 600 index .STOXX closed up 0.3% in
a volatile session, taking weekly gains to 0.3%.
Novo Nordisk NOVOb.CO rose 2.6% after the U.S. Food and
Drug Administration approved an oral version of its diabetes
drug, semaglutide. Global equity markets were spooked at the start of the week
by the Saudi attacks that sent oil prices soaring and fanned
geopolitical concerns. But cues of further monetary stimulus by
central banks around the world calmed investor nerves later in
the week.
The oil and gas sector .SXEP gained 3.4% in the week - its
biggest weekly increase in four months. O/R
Retailers also led the benchmark STOXX 600 higher, with
shares of Casino CASP.PA up 3.8% after the debt-laden company
said it was in talks to sell its discount store chain, Leader
Price, to German rival Aldi.
Friday's volatility also stemmed from "quadruple witching",
where investors unwound positions in futures and options
contracts before they expired.
In the week ahead, investors will also be watching for
economic data from the euro zone and the United States,
including preliminary PMIs and economic growth figures.
Shares in some of the biggest outperformers this year were
weighing on the STOXX 600. Airbus AIR.PA , up 43% so far this
year, was down 3.2%, and steady dividend-paying companies
including Unilever ULVR.L and British American Tobacco
BATS.L were down at least 1.5%.
The London-listed of these companies pushed the FTSE 100
.FTSE down 0.2%. It ended the week 0.3% lower, breaking a
three-week streak of gains.
The past few weeks saw investors rotate out of growth
sectors and into value stocks, with beaten-down shares of banks
in popular demand. However, the European banking index .SX7P
closed the week down 1% as investors went back into the safety
sectors.
Shares in Denmark's Jyske Bank JYSK.CO jumped 5.3% to the
top of the STOXX 600 after the lender said people with more than
$111,100 in their accounts would be charged a deposit rate as it
seeks to pass on some of the costs of recent rate cuts by the
European and Danish central banks.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.